An altered histaminergic innervation of the substantia nigra in Parkinson's disease

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 20-30

  Anichtchik, Oleg V ^a,b   Rinne, Juha O ^b   Kalimo, Hannu ^c,d   Panula, Pertti ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dopamine; Histaminergic system; Human brain; Parkinson's disease; Substantia nigra

Indexed keywords

HISTIDINE DECARBOXYLASE;

ADULT; AGED; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0034122975     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7362     Document Type: Article

References (60)

1. Airaksinen M. S., Paetau A., Paljärvi L., Reinikainen K., Riekkinen P., Suomalainen R., Panula P. Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer diseased brains. Neuroscience. 44:1991;465-481.
2. Airaksinen M. S., Panula P. The histaminergic system in the guinea pig central nervous system: An immunocytochemical mapping study using an antiserum against histamine. J. Comp. Neurol. 273:1988;163-186.
3. Airaksinen M. S., Flügge G., Fuchs E., Panula P. Histaminergic system in the tree shrew brain. J. Comp. Neurol. 286:1989;289-310.
4. Banati R. B., Daniel S. E., Blunt S. B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13:1998;221-227.
5. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
6. Cacabelos R., Yamatodani A., Niigawa H., Hariguchi S., Tada K., Nishimura T., Wada H., Brandeis L., Pearson J. Brain histamine in Alzheimer disease. Methods Find. Exp. Clin. Pharmacol. 11:1989;353-360.
7. Cadman E. D., Whittle D. G., Lee C. M. Regulation of the release of interleukin-6 from human astrocytoma cells. J. Neurochem. 63:1994;980-987.
8. 3-receptor subtypes. Br. J. Pharmacol. 107:1992;919-923.
9. Czlonkowska A., Kohutnicka M., Kurkowska-Jastrzebska I., Czlonkowski A. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration. 5:1996;137-143.
10. Fleckenstein A. E., Lookingland K. J., Moore K. E. Differential effects of histamine on the activity of hypothalamic dopaminergic neurons in the rat. J. Pharmacol. Exp. Ther. 268:1994;270-276.
11. Fogel W. A., Andrzejewski W., Maslinski C. Brain histamine in rats with hepatic encephalopathy. J. Neurochem. 56:1991;38-43.
12. Garbarg M., Javoy-Agid F., Schwartz J. C., Agid Y. Brain histidine decarboxylase activity in Parkinson's disease. Lancet. 1:1983;74-75.
13. Garbarg M., Baudry M., Benda P., Schwartz J. C. Simultaneous presence of histamine-N-methyltransferase and catechol-O-methyltransferase in neuronal and glial cells in culture. Brain Res. 81:1974;61-64.
14. Heikkila R. E., Sieber B. A., Manzino L., Sonsalla P. K. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol. Chem. Neuropathol. 10:1989;171-183.
15. Hill S. J., Ganellin C. R., Timmerman H., Schwartz J. C., Shankley N. P., Young J. M., Schunack W., Levi R., Haas H. L. International union of pharmacology XIII Classification of histamine receptors. Pharmacol. Rev. 49:1997;253-278.
16. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology. 42:1992;1142-1146.
17. Javoy-Agid F., Ploska A., Agid Y. Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and parkinsonian brains. J. Neurochem. 37:1981;1218-1227.
18. Langlais P. J., Zhang S. X., Weilersbacher G., Hough L. B., Barke K. E. Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy. J. Neurosci. Res. 38:1994;565-574.
19. Langston J. W., Ballard P. A., Tetrud J. W., Irwin I. Chronic parkinsonism in human due to a product of meperydine-analog synthesis. Science. 219:1983;979-980.
20. Leurs R., Smit M. J., Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharm. Ther. 66:1995;413-463.
21. Lieb K., Schaller H., Bauer J., Berger M., Schulze-Osthoff K., Fiebich B. L. Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6. J. Neurochem. 37:1998;1577-1583.
22. Lipnik-Stangelj M., Juric D. M., Carman-Krzan M. Histamine-induced synthesis and secretion of nerve growth factor from astrocytes. Inflam. Res. 47:1998;S34-S35.
23. Lloyd K. G., Möhler H., Hertz P., Bartolini G. Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and parkinsonian patients. J. Neurochem. 25:1975;789-795.
24. Lloyd K. G., Hornykiewicz O. L-glutamic acid decarboxylase in Parkinson's disease: Effect of l-dopa therapy. Nature. 243:1973;521-523.
25. Maeda A. T., Kimura H., Nagai T., Imai H., Arai R., Sakumoto T., Sakai K., Kitahama K., Jouvet M. Histochemistry of the magnocellular neurons in the posterior hypothalamus with special reference to MAO activity and ability of 5-HTP uptake and decarboxylation. Acta Histochem. Cytochem. 17:1984;179-193.
26. Manning K. A., Wilson J., Uhlrich D. Histamine-immunoreactive neurons and their innervation of visual regions in the cortex, tectum, and thalamus in the primate Macaca mulatta. J. Comp. Neurol. 373:1996;271-282.
27. 2 receptors in Huntington's chorea but not in Parkinson's disease: Comparison with animal models. Synapse. 15:1993;209-220.
28. Mazurkiewicz-Kwilecki I. M., Prell G. D. Age-related changes in brain histamine. Agents Actions. 14:1984;554-557.
29. Mazurkiewicz-Kwilecki I. M., Nsonwah S. Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. Can. J. Physiol. Pharmacol. 57:1989;75-78.
30. Molinari S. P., Kaminski R., Di Rocco A., Yahr M. D. The use of famotidine in the treatment of Parkinson's disease: A pilot study. J. Neural Transm. Park Dis. Dement. Sect. 9:1995;243-247.
31. 1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol. Psychiatry. 30:1991;349-356.
32. Nakamura S., Vincent S. R. Histochemistry of MPTP oxidation in the rat brain: Sites of synthesis of the parkinsonism-inducing toxin MPP+. Neurosci. Lett. 65:1986;321-325.
33. Nakamura S., Ohnishi K., Nishimura M., Suenaga T., Akiguchi I., Kimura J., Kimura T. Large neurons in the tuberomammilary nucleus in patients with Parkinson's disease and multiple system atrophy. Neurology. 4:1996;1693-1696.
34. Ong W. Y., He Y., Garey L. J. Localisation of glutamate receptors in the substantia nigra pars compacta of the monkey. J. Hirnforsch. 38:1997;291-298.
35. Panula P., Takagi H., Inagaki N., Yamatodani A., Tohyama M., Wada H., Kotilainen E. Histamine-containing nerve fibers innervate human cerebellum. Neurosci. Lett. 160:1993;53-56.
36. Panula P., Yang H. Y. T., Costa E. Histamine-containing neurons in the rat hypothalamus. Proc. Natl. Acad. Sci. USA. 81:1984;2572-2576.
37. Panula P., Rinne J., Kuokkanen K., Eriksson K. S., Sallmen T., Kalimo H., Relja M. Neuronal histamine deficit in Alzheimer's disease. Neuroscience. 82:1998;993-997.
38. Panula P., Airaksinen M. S., Pirvola U., Kotilainen E. A histamine-containing neuronal system in human brain. Neuroscience. 34:1990;127-132.
39. Panula P., Pirvola U., Auvinen S., Airaksinen M. S. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience. 28:1989;585-610.
40. Philippu A., Bald M., Kraus A., Dietl H. In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus. Naunyn-Schmiedebergs's Arch. Pharmacol. 326:1984;116-123.
41. Pioro E. P., Mai J. K., Cuello A. C. Distribution of substance P- and enkephalin-immunoreactive neurons and fibers. Paxinos G. The Human Nervous System. 1990;1051-1094 Academic Press, San Diego.
42. Prell G. D., Green J. P. Measurement of histamine metabolites in brain and cerebrospinal fluid provides insights into histaminergic activity. Agents Actions. 41:1994;C5-C8.
43. Prell G. D., Green J. P., Kaufmann C. A., Khandelwal J. K., Morrishow A. M., Kirch D. G., Linnoila M., Wyatt R. J. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: Their relationships of other aminergic transmitters and ratings of symptoms. Schizophr. Res. 14:1995;93-104.
44. Riederer P., Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J. Neural Transm. 38:1976;277-301.
45. Rigby M., Le Bourdellès B., Heavens R. P., Kelly S., Smith D., Butler A., Hammans R., Hills R., Xuereb J. H., Hill R. G., Whiting P. J., Sirinathsinghji D. J. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience. 73:1996;429-447.
46. 3 receptors following destruction of the ascending dopaminergic neurons. Br. J. Pharmacol. 118:1996;585-592.
47. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin, and their metabolites in Parkinson's disease. Brain Res. 275:1983;321-328.
48. Schaltenbrand G., Wahren W. Atlas of Sereotaxy of the Human Brain. 1977;Theime, Stuttgart.
49. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62:1994;65-85.
50. 3 receptors. J. Neural Transm. 93:1993;1-10.
51. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schimiedeberg's Arch. Pharmacol. 337:1988;588-590.
52. Schwartz J. C., Arrang J. M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71:1991;1-51.
53. Snyder A. M., Zigmond M. J., Lund R. D. Sprouting of serotonin afferents into striatum after dopamine-depleting lesions in infant rats: A retrograde transport and immunohistochemical study. J. Comp. Neurol. 245:1986;274-281.
54. Sukhov R. R., Walker L. C., Rance N. E., Price D. L., Young W. S. 3rd. Opioid precursor gene expression in the human hypothalamus. J. Comp. Neurol. 353:1995;604-622.
55. Takeda N., Inagaki S., Shiosaka S., Taguchi Y., Oertel W. H., Tohyama M., Watanabe T., Wada H. Immunohistochemical evidence for the coexistence of histidine decarboxylase-like and glutamate decarboxylase-like immunoreactivities in nerve cells of the magnocellular nucleus of the posterior hypothalamus of rats. Proc. Natl. Acad. Sci. USA. 81:1984;7647-7650.
56. Tuomisto L., Tacke U., Willman A. Inhibition of sound-induced convulsion by metoprine in the audiogenic seizure susceptible rat. Agents Actions. 14:1987;558-560.
57. Vorobjev V. S., Sharonova I. N., Walsh I. B., Haas H. L. Histamine potentates N-methyl-D-aspartate responses in acutely isolated hippocampal neurons. Neuron. 11:1993;837-844.
58. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats: A fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 295:1984;13-25.
59. Waters C. M., Peck R., Rossor M., Reynolds G. P., Hunt S. P. Immunohistochemical studies in the basal ganglia and substantia nigra in Parkinson's disease and Huntington's disease. Neuroscience. 24:1988;419-438.
60. Yamauchi K., Sato R., Tanno Y., Ohkawara Y., Maeyama K., Watanabe T., Satoh K., Yoshizawa M., Shibahara S., Takishima T. Nucleotide sequence of the histidine decarboxylase cDNA derived from human basophilic leukemia cell line, KU-812-F. Nucleic Acids Res. 18:1990;5891-5891.